The Journal of Experimental Medicine · 2022 · 48 citations · 31 references
Life SciencesImmunologyOncologyCancer ImmunologyMolecular OncologyTumor ImmunologyHelper T Cell SubsetsImmune Cell Lineage CommitmentT Cell ActivationT Cell BiologyT Cell DifferentiationT Cell Responses To TumorsCd4 Positive T CellsCd8 Positive T Cell DifferentiationCd8 Positive T CellsCytotoxicity AssaysHelper T Cell DifferentiationLymphocyte Lineage CommitmentT Cell CytotoxicityTumor Reactivity
Transcription factors ThPOK and Runx3 regulate the differentiation of "helper" CD4+ and "cytotoxic" CD8+ T cell lineages respectively, inducing single positive (SP) T cells that enter the periphery with the expression of either the CD4 or CD8 co-receptor. Despite the expectation that these cell fates are mutually exclusive and that mature CD4+CD8+ double positive (DP) T cells are present in healthy individuals and augmented in the context of disease, yet their molecular features and pathophysiologic role are disputed. Here, we show DP T cells in murine and human tumors as a heterogenous population originating from SP T cells which re-express the opposite co-receptor and acquire features of the opposite cell type's phenotype and function following TCR stimulation. We identified distinct clonally expanded DP T cells in human melanoma and lung cancer by scRNA sequencing and demonstrated their tumor reactivity in cytotoxicity assays. Our findings indicate that antigen stimulation induces SP T cells to differentiate into DP T cell subsets gaining in polyfunctional characteristics.
31
Community detection algorithms: A comparative analysis
Andrea Lancichinetti, Santo Fortunato · Physical Review E · 2009 · 2.2K citations · Full text
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
Moshe Sade-Feldman, Keren Yizhak, Stacey L. Bjorgaard et al. · Cell · 2018 · 2K citations · Full text
Life Sciences, Immunology, Oncology +14
Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors
Thomas Duhen, Rebekka Duhen, Ryan Montler et al. · Nature Communications · 2018 · 946 citations · Full text
Life Sciences, Immunology, Oncology +17